Search by Drug Name or NDC

    NDC 68382-0538-30 Potassium Citrate 15 meq/1 Details

    Potassium Citrate 15 meq/1

    Potassium Citrate is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals (USA) Inc.. The primary component is POTASSIUM CITRATE.

    Product Information

    NDC 68382-0538
    Product ID 68382-538_b0382b88-fcc4-44de-b66d-a93dabc596f8
    Associated GPIs 56202010200460
    GCN Sequence Number 065955
    GCN Sequence Number Description potassium citrate TABLET ER 15 MEQ ORAL
    HIC3 R1S
    HIC3 Description URINARY PH MODIFIERS
    GCN 28095
    HICL Sequence Number 000548
    HICL Sequence Number Description POTASSIUM CITRATE
    Brand/Generic Generic
    Proprietary Name Potassium Citrate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Potassium Citrate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 15
    Active Ingredient Units meq/1
    Substance Name POTASSIUM CITRATE
    Labeler Name Zydus Pharmaceuticals (USA) Inc.
    Pharmaceutical Class Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA203546
    Listing Certified Through 2024-12-31

    Package

    NDC 68382-0538-30 (68382053830)

    NDC Package Code 68382-538-30
    Billing NDC 68382053830
    Package 10 BLISTER PACK in 1 CARTON (68382-538-30) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
    Marketing Start Date 2014-08-12
    NDC Exclude Flag N
    Pricing Information N/A